Bioequivalence and Tolerability of 2 Lurasidone Formulations: A Randomized, Single‐Dose, 2‐Period, Crossover Study in Healthy Chinese Subjects Under Fasting and Fed Conditions

Ähnliche Einträge

• Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
  von: Pan Luo, et al.
  Veröffentlicht: (2026)
• Pharmacokinetics and Safety Evaluation of a New Generic Sitafloxacin: A Phase I Bioequivalence Study in Healthy Chinese Participants
  von: Yongfang Lei, et al.
  Veröffentlicht: (2025)
• Comparative Bioequivalence Study of 2 Clevidipine Formulations in Healthy Chinese participants: A Single‐Dose, 2‐Period Crossover Trial
  von: Zhuo Chen, et al.
  Veröffentlicht: (2025)
• Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
  von: Yongtao Li, et al.
  Veröffentlicht: (2024)
• Bioequivalence Analysis of Clindamycin Hydrochloride Capsules in Healthy Chinese Subjects Under Fasted and Fed Conditions
  von: Zhi Wang, et al.
  Veröffentlicht: (2024)